Skip to main content
Skip to main content
Back to Blog
StartupsTorontoResearch

AI in Canadian Healthcare: The Complete Guide to Startups, Hospitals, and Regulations

Complete guide to AI healthcare in Canada—from Deep Genomics and BenchSci drug discovery to Signal 1 hospital AI, SickKids innovations, and Health Canada's 2025 MLMD regulations.

A

AGI House Canada

Community Team

January 13, 202611 min read
AI in Canadian Healthcare: The Complete Guide to Startups, Hospitals, and Regulations

Canada's healthcare AI ecosystem is uniquely positioned—deep learning was invented here, and the same researchers who created modern AI are now applying it to save lives. From Toronto-based startups transforming drug discovery to hospitals deploying AI that predicts patient deterioration, Canadian healthcare AI is moving from research labs to clinical practice.

This is the complete guide to AI in Canadian healthcare—the startups, the hospital implementations, the regulatory landscape, and the opportunities.

What Is the Canadian Healthcare AI Landscape?

Canada's healthcare AI ecosystem combines academic research strength, government support, and a universal healthcare system that provides rich datasets for AI training.

Why Canada for Healthcare AI

AdvantageExplanation
Deep Learning OriginsAI invented at U of T by Hinton, connections to healthcare startups
Universal HealthcareSingle-payer system provides comprehensive health data
Research HospitalsUHN, SickKids, Unity Health with research mandates
Vector InstituteAI research institute partnering with hospitals
Regulatory EnvironmentHealth Canada developing AI-specific guidance

Key Healthcare AI Hubs

CityStrengths
TorontoDeep Genomics, BenchSci, Signal 1, UHN, SickKids
MontrealMila health AI research, McGill Health Centre
VancouverCanexia Health, BC Cancer Agency AI

What Are the Major Canadian Healthcare AI Startups?

Deep Genomics

Deep Genomics is a Toronto-based AI drug discovery company founded by Brendan Frey, who studied under Geoffrey Hinton at the University of Toronto in the 1990s and later co-founded the Vector Institute.

DetailInformation
Founded2014, Toronto
FounderBrendan Frey (U of T professor, Vector Institute co-founder)
FocusAI-powered genetic medicine discovery
Total Funding220M+ USD
Major Round180M USD (2021, SoftBank Vision Fund 2 led)
Key InvestorsSoftBank, CPP Investment Board, Fidelity

Frey's insight came in the early 2000s after the human genome was sequenced: AI could be used to understand the genetic basis of disease and design treatments. Deep Genomics uses machine learning to analyze genetic data and identify drug candidates for genetic diseases.

"CPPIB's thematic investing team always identified Deep Genomics as being a world-class machine learning team." — CPP Investment Board on their investment thesis

BenchSci

BenchSci is a Toronto-based AI platform that helps pharmaceutical companies accelerate drug discovery by using machine learning to decode scientific literature.

DetailInformation
Founded2015, Toronto
Total Funding218M USD (170M USD equivalent)
Latest Round95M CAD Series D (May 2023)
Lead InvestorGeneration Investment Management (Al Gore's fund)
Customers16 of world's top 20 pharma companies
Employees201-500 (July 2024)

BenchSci's platform, ASCEND, uses AI to help scientists find relevant research, identify promising drug targets, and design better experiments.

MetricPerformance
Revenue Growth191% (3-year)
RecognitionGlobe and Mail's Canada's Top Growing Companies 2024
Customer BaseMajor pharma including top 20 companies

Signal 1

Signal 1 represents a different model—AI developed inside a hospital and spun out as a startup with deep clinical validation.

DetailInformation
FoundedToronto
Co-foundersTomi Poutanen (Vector Institute co-founder), Mara Lederman (Rotman)
First InvestorGeoffrey Hinton (2024 Nobel Laureate)
Funding10M CAD (initial round)
OriginUnity Health Toronto / St. Michael's Hospital

Tomi Poutanen studied under Geoffrey Hinton and later co-founded the Vector Institute. Signal 1's first product, CHARTWatch, was developed at St. Michael's Hospital by Muhammad Mamdani, VP of data science at Unity Health Toronto.

CHARTWatch: The Core Product

FeatureCapability
FunctionReal-time patient risk predictor
InputCommonly collected patient data
OutputMortality risk prediction
IntegrationClinical workflows
BenefitEarlier interventions, reduced length-of-stay

CHARTWatch predicts which hospital patients are likely to deteriorate and which are clinically stable, enabling earlier interventions that save lives.

Partnerships

Signal 1 has partnered with Unity Health Toronto, TD Bank Group (through Layer 6, their AI division), to bring clinically-validated AI applications to hospitals globally.

Cyclica (Acquired)

Cyclica was a Toronto AI drug discovery company focused on polypharmacology—understanding how drugs interact with multiple proteins.

DetailInformation
Founded2013, Toronto
Total Funding~23M CAD
FocusPolypharmacology, multi-target drug design
TechnologyMatchMaker and POEM machine learning engines
InvestorsDrive Capital, Bill & Melinda Gates Foundation, Chiesi
StatusAcquired by Recursion Pharmaceuticals

Cyclica's platform enabled multi-objective evaluation of drug candidates, helping predict off-target effects and design safer drugs. The company launched spin-out Perturba Therapeutics in 2022 for AI-enabled oncology drug design before being acquired by Recursion.

How Are Canadian Hospitals Deploying AI?

University Health Network (UHN)

UHN—Canada's largest research hospital network—has multiple AI initiatives:

InitiativeFocus
Peter Munk Cardiac CentreAI for cardiac imaging
Princess Margaret Cancer CentreAI for radiation planning
Data & AnalyticsEnterprise AI infrastructure

SickKids (Hospital for Sick Children)

SickKids has ambitious AI programs focused on pediatric care:

InitiativeDescription
Precision Child HealthGenomic and data-driven care
SickKids AI (SKAI)Hospital-wide AI program
Emergency Care AIAI to improve pediatric emergency triage

"At SickKids, AI is used to improve paediatric emergency care—one of many ways Canada's AI expertise is reshaping medicine." — Associations Now (2025)

Unity Health Toronto

Unity Health (including St. Michael's Hospital) is where Signal 1's CHARTWatch was developed and validated:

RoleContribution
DevelopmentCHARTWatch built in-house
ValidationClinical testing and refinement
PartnershipSignal 1 collaboration for commercialization
LeadershipMuhammad Mamdani, VP Data Science

What Is Health Canada's AI Regulation Framework?

In February 2025, Health Canada released comprehensive guidance for machine learning-enabled medical devices (MLMDs), providing clarity for companies developing AI healthcare products.

Key Regulatory Framework

ElementDescription
ClassificationMLMDs classified as Class II, III, or IV devices
Risk-BasedHigher risk = more regulatory requirements
DisclosureML use must be explicitly disclosed in applications
International AlignmentFollows IMDRF definitions and principles

Predetermined Change Control Plans (PCCP)

One of the most significant innovations in Health Canada's guidance is the PCCP concept:

FeaturePurpose
Pre-authorizationApprove future ML model updates in advance
Known RisksAddress anticipated changes to ML systems
MonitoringTerms and conditions on device licenses
FlexibilityAllow AI systems to improve post-market

This addresses a fundamental challenge in AI regulation: ML models improve over time, but traditional medical device approval assumes a static product.

International Coordination

OrganizationInitiative
IMDRF10 guiding principles for Good ML Practice (January 2025)
FDAJoint transparency principles with Health Canada
MHRA (UK)Trilateral guidance coordination

Regulatory Status

LegislationStatus
Health Canada MLMD GuidanceFinal (February 2025)
AIDA (Artificial Intelligence and Data Act)Died on Order Paper (January 2025)
Medical Devices RegulationsActive, applying to MLMDs

What Is the Vector Institute's Role in Healthcare AI?

The Vector Institute, co-founded by Geoffrey Hinton in 2017, plays a central role in connecting AI research to healthcare applications.

Healthcare Partnerships

PartnershipFocus
Ontario HospitalsAI research collaboration
Unity HealthCHARTWatch development
IndustryTechnology transfer

Healthcare AI Research

AreaExamples
Clinical PredictionPatient deterioration, readmission risk
Medical ImagingRadiology AI, pathology
Drug DiscoveryMolecular design, target identification
Health OperationsScheduling, resource allocation

What Are the Career Opportunities in Canadian Healthcare AI?

Healthcare AI offers unique career paths combining technical skills with clinical impact.

In-Demand Roles

RoleTypical Background
ML Engineer (Healthcare)CS/Engineering + healthcare domain
Clinical Data ScientistStatistics/ML + clinical understanding
Regulatory Affairs (AI)Life sciences + regulatory experience
Product Manager (Health AI)Technical + healthcare strategy
Bioinformatics ScientistBiology + computational skills

Salary Ranges (Toronto, 2026)

RoleRange (CAD)
ML Engineer150K-220K
Data Scientist (Pharma)130K-180K
Regulatory Affairs100K-150K
Product Manager (AI)140K-200K

Key Employers

CategoryCompanies
StartupsDeep Genomics, BenchSci, Signal 1
PharmaGSK, Sanofi, Bayer (Toronto offices)
HospitalsUHN, SickKids, Unity Health
ResearchVector Institute, Mila

Frequently Asked Questions

What are the major Canadian healthcare AI startups?

The major Canadian healthcare AI startups include Deep Genomics (AI drug discovery, 220M+ USD raised), BenchSci (AI for pharma research, 218M USD raised, serves 16 of top 20 pharma companies), and Signal 1 (hospital AI for patient risk prediction). All three are based in Toronto and have deep connections to the Vector Institute and University of Toronto AI ecosystem.

What is Deep Genomics?

Deep Genomics is a Toronto-based AI drug discovery company founded by Brendan Frey, who studied under Geoffrey Hinton and co-founded the Vector Institute. The company uses machine learning to analyze genetic data and develop treatments for genetic diseases. It has raised over 220M USD, including a 180M USD round led by SoftBank Vision Fund 2 and CPP Investment Board.

What is BenchSci?

BenchSci is a Toronto AI company that helps pharmaceutical companies accelerate drug discovery using machine learning. Their ASCEND platform analyzes scientific literature to help scientists find relevant research and design better experiments. BenchSci has raised 218M USD and counts 16 of the world's top 20 pharma companies as customers.

What is Signal 1 and CHARTWatch?

Signal 1 is a Toronto health AI startup co-founded by Tomi Poutanen (Vector Institute co-founder) with Geoffrey Hinton as its first investor. Their core product, CHARTWatch, was developed at Unity Health Toronto and predicts which hospital patients are at risk of deterioration, enabling earlier interventions that save lives.

How is AI used in Canadian hospitals?

Canadian hospitals deploy AI for clinical prediction (patient deterioration, readmission risk), medical imaging (radiology, pathology), drug discovery support, and operational optimization. SickKids runs the SKAI program for pediatric AI, UHN uses AI across cardiac and cancer care, and Unity Health Toronto developed the CHARTWatch patient risk system.

What is Health Canada's AI regulation framework?

Health Canada released its Pre-market Guidance for Machine Learning-enabled Medical Devices (MLMDs) in February 2025. The framework uses risk-based classification (Class II-IV), requires explicit ML disclosure, and introduces Predetermined Change Control Plans (PCCPs) that allow pre-authorization of future model updates—addressing the challenge that AI systems improve over time.

What is a Predetermined Change Control Plan (PCCP)?

A PCCP is a mechanism introduced by Health Canada for AI medical devices that allows manufacturers to pre-authorize planned changes to ML systems. This addresses the fundamental challenge that AI models improve over time, while traditional medical device approval assumes static products. PCCPs enable AI systems to be updated while maintaining safety oversight.

What career opportunities exist in Canadian healthcare AI?

Healthcare AI careers include ML Engineers (150K-220K CAD), Clinical Data Scientists (130K-180K CAD), Regulatory Affairs specialists for AI/ML devices, and Product Managers. Key employers include startups (Deep Genomics, BenchSci, Signal 1), pharma companies with Toronto presence, research hospitals (UHN, SickKids), and research institutes (Vector Institute, Mila).


Related Reading

Canadian AI Ecosystem

Canadian AI Startups

Canadian AI Careers

Research and Policy


Join AGI House Canada to connect with Toronto's healthcare AI community. Scan the QR code to join our WhatsApp group or subscribe to our newsletter.

Data current as of January 2026. Information from Health Canada, BetaKit, University of Toronto, Vector Institute, company announcements, and regulatory guidance documents.

Share this post
A

AGI House Canada

Community Team